Reduction of major adverse cardiac events with intracoronary compared with intravenous bolus application of abciximab in patients with acute myocardial infarction or unstable angina undergoing coronary angioplasty.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples